Vidas

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 assays automated caused clinical clinical sensitivity clinical specificity coefficients Combined coronavirus COVID-19 COVID-19 pandemic cross-reactivity declined Diagnosis Emergency use authorization epidemiological epidemiological surveillance healthy donor Hospitalized IgG IgG responses IgM and IgG IgM/IgG immunoserology Infection pandemic Patient patients performance positive Precision reached remained respiratory respiratory virus response reverse transcriptase reverse transcriptase PCR RT-PCR SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgM SARS-CoV-2 infections SARS-CoV-2 patients SARS-CoV-2 PCR SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody sensitivity sera Seroconversion Serological assay serological assays serological test Serological testing Serological tests significantly higher specific IgM specificity Spread Surveillance symptom onset test results Variation Vidas virus infection was determined
[DOI] 10.1128/JCM.02292-20 PMC 바로가기 [Article Type] Immunoassays